Canine Arthritis Treatment Market Report and Forecast 2025-2034

The global canine arthritis treatment market stood at a value of nearly USD 2.32 Billion in 2024. The market is further expected to grow at a CAGR of 5.00% in the forecast period of 2025-2034 to reach value of around USD 3.78 Billion by 2034.

North America Dominates the Canine Arthritis Treatment Industry Globally

North America is the leading canine arthritis treatment market globally and the region is expected to maintain its dominance in the forecast period as well. The growth can be attributed to the increased pet adoptions and the high expenditure on pet care in the region. Within North America, the United States significantly contributes to the industry growth. According to the American Pet Products Association, the US pet owners spent over USD 7.4 billion on vet care in 2017. This demonstrates high awareness regarding the health of pet among the general population in the region. Europe follows North America in terms of market value, with around USD 6.1 billion spending on vet care in the same year. Meanwhile, the Asia-Pacific is expected to witness a relatively higher growth in the forecast period owing to the expanding pet care market in emerging nations like India. The growing awareness regarding canine arthritis treatment in such regions are expected to provide enhanced growth opportunities to the market in the coming years.

Canine Arthritis Treatment: Market Segmentation

Canine arthritis is a medical condition in pets that results in inflammation in joints, thereby affecting knee, elbow, spinal cord, and other joints. Some of the causes of canine arthritis in dogs include accidental injuries, obesity, repetitive stress from athletic activities, and improper nutrition. The lack of treatment can lead to a substantial increase in inflammation and pain and decreased range of motion. However, early detection of problem and its proper management can help pets to remain active. The most common form of arthritis is osteoarthritis, which is commonly known as degenerative joint disease (DJD). Generally, osteoarthritis treatment is multimodal, that is, it involves the use of several different therapies simultaneously to achieve the best result. The treatment is typically focused on reducing pain, controlling inflammation, improving quality of life, and slowing the development of the disease.

By treatment, the market is divided into:

• Non-Steroidal Anti-Inflammatory Medications (NSAIDs)
• Opioids
• Stem Cell Therapy
• Others

The market is divided based on route of administration into:

• Oral
• Injectable

On the basis of distribution channel, the industry can be segmented into:

• Veterinary Hospitals and Clinics
• Retail Pharmacies
• Online
• Others

The regional markets for the product include:

• North America
• Europe
• Asia-Pacific
• Latin America
• Middle East and Africa

Rising Prevalence of Osteoarthritis in Dogs and the Growing Pet Care Market to Bolster the Growth of the Canine Arthritis Treatment Industry

The increasing incidences of arthritis in dogs, particularly osteoarthritis, is the major factor driving the growth of the canine arthritis treatment industry. Osteoarthritis affects as many as one in five dogs and is a common problem in older dogs and large breeds. The development of osteoarthritis in pets can be prevented through proper diet, exercise, and the use of protective joint supplements. The canine arthritis treatment industry is further supported by the growing pet care market, particularly in developing nations like India. Over the forecast period, increasing awareness regarding canine arthritis treatment is expected to further accelerate the market growth.

Due to the outbreak of the COVID-19 pandemic, nonessential vet visits have been restricted, however, there has been a spike in adoption of pets and foster applications in 2020. The shelters across the United States have reported a rise in foster applications as people prepare to spend more time at home amidst the lockdown. This is expected to aid the industry growth in the forecast period.

Key Industry Players in the Global Canine Arthritis Treatment Market

The report gives a detailed analysis of the following key players in the global canine arthritis treatment industry, covering their competitive landscape, capacity, and latest developments like mergers, acquisitions, and investments, expansions of capacity, and plant turnarounds:

• Boehringer Ingelheim (Canada) Ltd.
• America Regent, Inc.
• Elanco Animal Health Incorporated
• Zoetis Services LLC
• American Regent, Inc.
• Others

The comprehensive report provides an in-depth assessment of the market based on the Porter's five forces model along with giving a SWOT analysis.